A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY FOLLOWED BY OPEN-LABEL TREATMENT OF ALTO-100 IN ADULTS WITH BIPOLAR DISORDER CURRENTLY EXPERIENCING A MAJOR DEPRESSIVE EPISODE...